BioSpace News Archive

Analysis is largest published study to date on Excimer Laser Trabeculostomy

Solution Uses Deep Learning Technology Allowing Hospitals, Pharmaceutical Companies, and Cancer Centers to Offer Better and Quicker Diagnoses While Developing More Effective Drugs and Therapeutic Interventions

Rafael Pharmaceuticals Inc., a leader in the growing field of cancer metabolism-based therapeutics, announced that Co-Chief Medical Officer, Timothy Pardee, M.D., Ph.D., will lead a poster presentation on the Phase 3 study of CPI-613® for the treatment of older patients with relapsed or refractory acute myeloid leukemia at the 61st Annual ASH Meeting and Exposition.

BioNovelus, Inc. (OTC: ONOV) announces that Trey Blalock joined the Company’s Advisory Board. BioNovelus’ Advisory Board seats individual entrepreneurs and senior Information Warfare, (IW), Cyber Security / Information Technology (IT) executives with business, government and technical expertise useful for assisting in identifying, integrating and growing acquired companies

Medical Marijuana, Inc. (“the Company”) (OTC: MJNA), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® received a Bronze Best in Biz Award

Ikonopedia announced that Marshfield Clinic in Eau, Wisconsin, has selected the company’s structured breast reporting and risk assessment tools to help improve reporting efficiency, and optimize facility operations.

Laboratory for Advanced Medicine, an AI-driven healthcare company focused on commercializing early cancer detection test from a simple blood draw, today announced the appointment of Christopher DeRosa, MBA, an industry leader in medical insurance and reimbursement, to the company’s Board of Directors.

Boston Biomedical, Inc. announced today that the company has entered into an alliance in oncology research with three world-leading oncology centers of excellence – Columbia University, Harvard University and The Wistar Institute.

Biocept, Inc. (NASDAQ: BIOC), announces that clinical data supporting the use of its Target Selector™ CTC platform as an aid in the monitoring and treatment of breast cancer will be presented in a poster session at the 2019 San Antonio Breast Cancer Symposium® (SABCS).

Tricida, Inc. (Nasdaq: TCDA), a pharmaceutical company focused on the development and commercialization of its drug candidate, veverimer (TRC101), a non-absorbed, orally-administered polymer designed to treat metabolic acidosis in patients with chronic kidney disease (CKD), today announced the hiring of Elizabeth Faust, Ph.D., as Senior Vice President of Medical Affairs